Lipitor vs. Crestor

The differences that affect prescribing

The comparison is not a conversion guide. We select a dose using the intended LDL reduction and your health, not by replacing one tablet with the same milligram amount of another. A switch should include a plan to review response and any symptoms.

Why the cholesterol number is only part of the decision

Someone who has already had a heart attack or stroke may need a different prevention strategy from someone with a modestly raised LDL and no established vascular disease. Diabetes, blood pressure, smoking and family history also matter. We review these factors before choosing treatment intensity.

Both medicines can support substantial LDL reduction at appropriate doses. Rosuvastatin is more potent on a milligram basis, but that does not make it automatically more suitable. The clinically useful comparison is whether an appropriate dose achieves the required response without an unacceptable interaction or adverse effect.

We explain the goal and when lipids will be checked. A good result usually shows that treatment is helping, not that the underlying risk has disappeared. Do not stop either statin solely because the laboratory report now falls within a reference range.

When the medicine list changes the choice

Atorvastatin is affected by medicines that alter CYP3A4 activity. Some antibiotics, antifungals and antiviral treatments can increase exposure and muscle risk. Rosuvastatin is less dependent on that pathway, but it has other significant interactions and dose restrictions. It should not be described as interaction-free.

Tell us about cyclosporine, fibrates, colchicine, warfarin and every other prescription or supplement. Some combinations require avoidance, a dose limit or monitoring. A short course can still matter, so include medicines used temporarily rather than only the daily long-term list.

• Bring actual medicine names and strengths, including combination tablets.
• Mention any new antibiotic, antifungal or antiviral course.
• Include red yeast rice and other cholesterol supplements.
• Tell us if another clinician advised a temporary statin pause and when it was meant to restart.

Kidney function and other health factors

Significant kidney impairment can change the suitable rosuvastatin dose. We review current results, not only a historical diagnosis. An acute kidney problem during illness can also alter the wider medicine plan and should be discussed before an older prescription is resumed unchanged.

Liver health, thyroid disease, age, previous muscle problems and alcohol intake can affect tolerability and risk. Some patients, including people of Asian ancestry, may need a lower starting rosuvastatin dose because exposure can be higher. These are individual prescribing considerations rather than a reason for everyone in a group to use the same regimen.

Pregnancy planning and breastfeeding require a separate discussion. Most patients stop statin treatment during pregnancy, with uncommon high-risk situations needing specialist input. Do not leave those decisions to a simple comparison table; contact the treating teams for an appropriate plan.

Muscle symptoms with either statin

Muscle pain or weakness deserves assessment, but it does not automatically prove that the statin is responsible. Exercise, infection, thyroid problems and other medicines can produce similar symptoms. Tell us where the symptoms occur and how they relate to starting treatment, changing the dose or adding another medicine.

Severe pain, marked weakness, dark urine or reduced urine output needs urgent assessment. Do not continue taking extra tablets or wait for a routine cholesterol appointment. Bring the medicine list and recent changes so the assessing clinicians can consider the risk of serious muscle injury.

For milder symptoms, we may consider relevant tests, an assessed pause, a lower dose or another treatment. Some people tolerate a different statin better, but a switch is not guaranteed to remove symptoms. The aim is to identify a workable prevention plan without dismissing either the discomfort or the cardiovascular benefit.

Comparing cost without changing the prescription

Both atorvastatin and rosuvastatin have generic options. The final medication cost depends on strength, quantity, pharmacy and the product supplied. A brand price and a generic price should not be treated as though they describe the same purchase, and different dose strengths may not represent the same treatment intensity.

The individual medication pages show the relevant product and supply information. We confirm the intended prescription before medication purchase rather than let a lower-priced pack determine the clinical dose. Consultation and monitoring arrangements should also be clear so the plan is practical to continue.

If affordability is causing missed doses, bring that concern before rationing tablets. A generic or a different supply arrangement may help. An apparently inexpensive regimen offers little benefit if it is repeatedly interrupted or does not address the reason treatment was prescribed.

How we review a switch

We first establish why a change is being considered. An inadequate LDL response, an interaction, a side effect and a supply problem are different reasons and may need different solutions. We confirm the dose actually taken, regular use and the latest results before replacing a medicine that may already be working.

A switch plan identifies the new medicine and dose, which old prescription stops and when response will be reviewed. Keep the updated instructions with your medication list. Do not continue both statins by accident because an old pack remains available or both appear on separate repeat lists.

At follow-up, we consider the lipid result and how you feel on treatment. Another medicine may be needed for some patients, while others do well with a tolerable statin alone. The plan is based on the intended protection and actual response rather than a preference for the more familiar brand.

Common questions